Governments and Health Organizations Undertaken Initiatives For Aspiration & Biopsy Needles

Breast Biopsy Market Information: By Technique Type (Biopsy Markers, Surgical Biopsy, MRI-guided Core Needle Biopsy), By Product (Biopsy Wires, Biopsy Needles), End-Users (Surgical and Diagnostic Centers)

Pune, India – June 19, 2019 —

A biopsy is a small operation that is used to perform the removal of tissues from an area of concern from the body.

Breast biopsy is a medical procedure that involves the testing of small samples of breast tissues for the detection of breast cancer.

The global Breast Biopsy Market is expected to expand in significant fashion during the forecast period of 2018 to 2023.

Core Biopsy Needles Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Core Biopsy Needles industry with a focus on the Chinese market.

The report provides key statistics on the market status of the Core Biopsy Needles manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Core Biopsy Needles market covering all important parameters.Critical Questions Addressed by the ReportWhat are the current trends that are driving the Core Biopsy Needlesmarket?Where will all these developments take the industry in the mid- to long-term?Who are the top vendors in the Core Biopsy Needlesmarket and what is their competitive analysis?How is adoption of Core Biopsy Needlessolutions among different industries?How is the adoption of Core Biopsy Needlessolutions among different regions?Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-core-biopsy-needles-2019-2024-429The key points of the report:The report provides a basic overview of the industry including its definition, applications and manufacturing technology.The report explores the international and Chinese major industry players in detail.

In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.Through the statistical analysis, the report depicts the global and Chinese total market of Core Biopsy Needles industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.The report then estimates 2019-2024 market development trends of Core Biopsy Needles industry.

Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.The report makes some important proposals for a new project of Core Biopsy Needles Industry before evaluating its feasibility.There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Core Biopsy Needles as well as some small players.At least 7 companies are included: BD Mammotome Argon Medical Devices HologicTo know more companiesFor complete companies list, please ask for sample pages.

14G-18G 18GFor end use/application segment, this report focuses on the status and outlook for key applications.

The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019 at a CAGR of 7.3%The market for aspiration and biopsy needles is primarily driven by the factors such as the rising prevalence of cancer, increasing preference for minimally invasive surgeries, and rise in cancer awareness initiatives undertaken by governments and global health organizations.Biopsy needles accounted for the largest share of the aspiration and biopsy needles market, by product, in 2018.On the basis of product, the aspiration and biopsy needles market is segmented into aspiration and biopsy needles.

The biopsy needles segment accounted for the largest share of the aspiration and biopsy needles market in 2018 due to its widespread adoption in healthcare facilities.

This segment is also expected to grow at the highest rate during the forecast period.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71036825The lung segment is expected to register the highest growth rate in the aspiration and biopsy needles market during the forecast period by site, in 2019 On the basis of site, the aspiration & biopsy needles market is segmented into breast, lung, colorectal, prostate, kidney, and bone & bone marrow.

The lung segment is expected to register the highest growth rate due to the increasing prevalence of lung cancer.North America held the largest share of the aspiration and biopsy needles market in 2019 The large share of the North American market can mainly be attributed to the increasing number of surgical procedures, technological advancements, rising demand for minimally invasive procedures, favorable reimbursement scenario, and rising government concerns regarding the health hazards of surgical plumes.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=71036825Leading CompaniesCONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US) are some of the leading players.

“Endoscopic Ultrasound Needles Market” study by “KD Market Insights” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues.

It concludes with precise and authentic market estimations considering all the parameters and market dynamics.

Every crucial and decisive detail for the development and restriction of the market is mentioned in fine points with solutions and suggestions that may affect the market in near future.

Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments.For Sample Report Click: https://www.kdmarketinsights.com/sample/5393Global Endoscopic Ultrasound Needles Market Segmentation Analysis:by various government agencies is one of the factor which is negatively impacting the growth of global endoscopic ultrasound needles market.Segmentation AnalysisThe endoscopic ultrasound needles market by product is segmented into aspiration needles (EUS-FNA) and biopsy needles (EUS-FNB).

The market for aspiration needles captured highest percentage in 2019.

Moreover, it is anticipated to continue its dominance during the forecast period.The report “Endoscopic Ultrasound Needles” gives varied description about the segmentation of the market on the basis of segmented Dosage, Route of Administration and Application, and leads with a descriptive structure of the trends and restrictions of the various segments and sub segments.

1 March 2019, The global Liquid Biopsy Market is projected to witness substantial growth over the forecast period (from 2017 to 2025) owing to advancement in liquid biopsy tests and extensive R by major companies.

Moreover, highly invasive nature and frequent complications associated with tissue biopsy and advancements in Next-Generation Sequencing (NGS) is anticipated to fuel demand for liquid biopsy in coming years.Liquid biopsies make use of bio fluid samples, such as blood, urine sample, tissue fluids, and saliva.

The technology is widely used in molecular health monitoring, therapy selection for Metastatic Breast Cancer (MBS), and other related cancers.

MBS is likely to emerge as a leading application over the forecast period as a result of growing cases of metastatic cancer across the world.

PCR-based sequencing is used for analysis of mutations in disease-specific genes, whereas NGS testing is used for simultaneous analysis of multiple diseases.

Rising awareness about benefits of multiple-gene analysis and NGS is projected to have a positive impact on the market growth over the next few years.The market can be segmented on the basis of geography as North America, Latin America, Asia Pacific, Europe, and MEA.